Mizuho Securities USA LLC Sells 9,680 Shares of Danaher Corporation (NYSE:DHR)

Key Points

• Mizuho Securities USA LLC reduced its holdings in Danaher Corporation by 15.9%, owning 51,245 shares worth approximately $10.51 million following the sale of 9,680 shares.
• Danaher reported $1.80 earnings per share for its latest quarter, exceeding analysts' expectations of $1.64, with revenue of $5.94 billion also surpassing forecasts.
• Analysts currently have 18 buy ratings and 3 hold ratings for Danaher, with an average price target of $247.61 for the stock.

Mizuho Securities USA LLC lessened its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 15.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,245 shares of the conglomerate's stock after selling 9,680 shares during the quarter. Mizuho Securities USA LLC's holdings in Danaher were worth $10,505,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of DHR. GAMMA Investing LLC lifted its holdings in shares of Danaher by 24,958.2% during the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock worth $383,524,000 after buying an additional 1,863,381 shares during the last quarter. Two Sigma Advisers LP lifted its holdings in shares of Danaher by 4,248.8% during the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock worth $376,347,000 after buying an additional 1,601,800 shares during the last quarter. Capital World Investors lifted its holdings in shares of Danaher by 32.7% during the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock worth $1,460,215,000 after buying an additional 1,566,658 shares during the last quarter. Point72 Asset Management L.P. lifted its holdings in shares of Danaher by 460.6% during the fourth quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock worth $309,558,000 after buying an additional 1,107,998 shares during the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Danaher during the fourth quarter worth approximately $242,837,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on DHR shares. UBS Group lowered their price objective on Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research report on Wednesday, July 23rd. Jefferies Financial Group lowered their price objective on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. TD Cowen boosted their price objective on Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a research report on Wednesday, April 23rd. Barclays restated an "overweight" rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Finally, Leerink Partners upped their price target on Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a research report on Wednesday, April 23rd. Three investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $247.61.

Danaher Price Performance

NYSE DHR traded down $0.73 during midday trading on Monday, hitting $199.83. The company had a trading volume of 2,565,844 shares, compared to its average volume of 4,853,395. The company has a market capitalization of $143.09 billion, a PE ratio of 42.52, a P/E/G ratio of 2.80 and a beta of 0.73. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average price of $198.68 and a 200-day moving average price of $200.30. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The company's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.72 EPS. As a group, analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.